Asmaa Gomaa

2.8k total citations · 1 hit paper
45 papers, 2.0k citations indexed

About

Asmaa Gomaa is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Asmaa Gomaa has authored 45 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Hepatology, 32 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Asmaa Gomaa's work include Liver Disease Diagnosis and Treatment (29 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Hepatitis C virus research (17 papers). Asmaa Gomaa is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Hepatitis C virus research (17 papers). Asmaa Gomaa collaborates with scholars based in Egypt, United Kingdom and Australia. Asmaa Gomaa's co-authors include Imam Waked, Simon D. Taylor‐Robinson, Shahid A. Khan, Mireille B. Toledano, I. Jane Cox, Wladyslaw Gedroyc, Naglaa Allam, Aisha Elsharkawy, Mohamed El‐Kassas and Edward Leen and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hepatology.

In The Last Decade

Asmaa Gomaa

41 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis

2008 548 citations Asmaa Gomaa, Shahid A. Khan et al. World Journal of Gastroenterology profile →

Peers

Asmaa Gomaa

HEPAT

EPIDE

ONCOL

Huiguo Ding China

Francesco Giuseppe Foschi Italy

Sahil Mittal United States

Lungen Lu China

I. Zagni Italy

Rachel Beckerman United States

Zongtang Sun China

Yinying Lu China

In Hee Kim South Korea

Ken Liu Australia

Huiguo Ding China

Asmaa Gomaa

1.0k ×0.9

HEPAT

1.1k ×1.1

EPIDE

756 ×1.2

450 ×1.0

217 ×0.8

ONCOL

Citations per year, relative to Asmaa Gomaa Asmaa Gomaa (= 1×) peers Huiguo Ding

Countries citing papers authored by Asmaa Gomaa

Since Specialization

Citations

This map shows the geographic impact of Asmaa Gomaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asmaa Gomaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asmaa Gomaa more than expected).

Fields of papers citing papers by Asmaa Gomaa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asmaa Gomaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asmaa Gomaa. The network helps show where Asmaa Gomaa may publish in the future.

Co-authorship network of co-authors of Asmaa Gomaa

This figure shows the co-authorship network connecting the top 25 collaborators of Asmaa Gomaa. A scholar is included among the top collaborators of Asmaa Gomaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asmaa Gomaa. Asmaa Gomaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

El‐Badri, Nagwa S., Ahmed Tawheed, Asmaa Gomaa, et al.. (2025). MiR-216a-3p inhibits the cytotoxicity of primary natural killer cells. Frontiers in Oncology. 14. 1523068–1523068. 1 indexed citations

Salama, Mohsen, et al.. (2024). Long-Term Outcomes of Patients with Liver Cirrhosis After Eradication of Chronic Hepatitis C with Direct-Acting Antiviral Drugs (DAAs). Journal of Hepatocellular Carcinoma. Volume 11. 2115–2132.

Gomaa, Asmaa, et al.. (2024). Evaluation of different scoring systems for repeating Transarterial Chemoembolization in Egyptian patients with Hepatocellular Carcinoma. Romanian Journal of Internal Medicine. 62(4). 430–439. 2 indexed citations

Assal, R.A., Noha Mousaad Elemam, Asmaa Gomaa, et al.. (2024). A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma. Translational Oncology. 45. 101961–101961. 18 indexed citations

Abdelsameea, Eman, et al.. (2023). Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection. SHILAP Revista de lepidopterología. 13(1).

Ezzat, Sameera, Ivane Gamkrelidze, Asmaa Gomaa, et al.. (2023). Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost‐effectiveness model. Liver International. 43(7). 1417–1426. 6 indexed citations

Shen, Eric Yi-Liang, Mark Thursz, Imam Waked, et al.. (2022). Optimized Systematic Review Tool: Application to Candidate Biomarkers for the Diagnosis of Hepatocellular Carcinoma. Cancer Epidemiology Biomarkers & Prevention. 31(7). 1261–1274. 1 indexed citations

Aref, Ahmed, et al.. (2022). Epithelial-Mesenchymal Transition Markers in HCVAssociated Hepatocellular Carcinoma: A Multivariate Follow Up Study. Asian Pacific Journal of Cancer Prevention. 23(3). 839–849. 6 indexed citations

Gomaa, Asmaa, et al.. (2021). Altered Protein and Gene Expression of Beclin-1 Correlates with Poor Prognosis of Hcv-Associated Hepatocellular Carcinoma in Egyptian Patients. Asian Pacific Journal of Cancer Prevention. 22(4). 1115–1122. 4 indexed citations

10.

Waziry, Reem, Asmaa Gomaa, Imam Waked, & Gregory J. Dore. (2018). Determinants of survival following hepatocellular carcinoma in Egyptian patients with untreated chronic HCV infection in the pre-DAA era. Arab Journal of Gastroenterology. 19(1). 26–32. 8 indexed citations

11.

Gomaa, Asmaa, Naglaa Allam, Aisha Elsharkawy, Mohamed El‐Kassas, & Imam Waked. (2017). Hepatitis C infection in Egypt: prevalence, impact and management strategies. SHILAP Revista de lepidopterología. Volume 9. 17–25. 135 indexed citations

12.

Mohamed, Zameer, Asmaa Gomaa, Mark Sonderup, et al.. (2017). Hepatitis C treatment: where are we now?. International Journal of General Medicine. Volume 10. 39–52. 72 indexed citations

13.

Esmat, Gamal, Tamer Elbaz, Maissa El Raziky, et al.. (2017). Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4. Journal of Hepatology. 68(1). 53–62. 12 indexed citations

14.

Estes, Chris, Wael Abdel‐Razek, Eman Abdelsameea, et al.. (2015). Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies. Alimentary Pharmacology & Therapeutics. 42(6). 696–706. 64 indexed citations

15.

Gomaa, Asmaa. (2015). Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. World Journal of Gastroenterology. 21(18). 5654–5654. 8 indexed citations

16.

Eltabbakh, Mohamed, et al.. (2014). Utility and cost-effectiveness of screening for hepatocellular carcinoma in a resource-limited setting. Medical Oncology. 32(1). 432–432. 19 indexed citations

17.

Shariff, Mohamed, Asmaa Gomaa, I. Jane Cox, et al.. (2011). Urinary Metabolic Biomarkers of Hepatocellular Carcinoma in an Egyptian Population: A Validation Study. Journal of Proteome Research. 10(4). 1828–1836. 82 indexed citations

18.

Cox, I. Jane, et al.. (2009). Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Review of Gastroenterology & Hepatology. 3(4). 353–367. 270 indexed citations

19.

Gomaa, Asmaa, Shahid A. Khan, Edward Leen, Imam Waked, & Simon D. Taylor‐Robinson. (2009). Diagnosis of hepatocellular carcinoma. World Journal of Gastroenterology. 15(11). 1301–1301. 124 indexed citations

20.

Gomaa, Asmaa, Shahid A. Khan, Mireille B. Toledano, Imam Waked, & Simon D. Taylor‐Robinson. (2008). Hepatocellular carcinoma: Epidemiology, risk factors and pathogenesis. World Journal of Gastroenterology. 14(27). 4300–4300. 548 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact